Medical Futurist Dr Bertalan Mesko unveiled as first keynote speaker for CPhI North America 2018

CPhI North America, the only event to bring the complete North American pharma supply chain together, has announced that The Medical Futurist Dr Bertalan Mesko, Director of The Medical Futurist Institute and Amazon Top 100 author of My Health: Upgraded and The Guide to the Future of Medicine, will present a keynote address as a core element of the 2nd Annual CPhI North America Conference.
Dr Mesko, a self-professed ‘geek physician’ with a PhD in genomics, envisions the impact of digital health technologies on the future of healthcare, helping patients, doctors, government regulators and companies work to make it a reality. At CPhI North America, his keynote address will focus on Science Fiction in Healthcare, and explore how science fiction becomes science fact, the role that patient-led design is having on technological developments, the new challenges presented by patients finding an unregulated, technological solution for health problems, how disruption is helping to tackle these new challenges, and how this is resulting in a cultural transformation as we move towards highly personalized, digital health solutions. Dr Mesko’s keynote takes place Tuesday April 24 from 1.30pm to 2.15pm, and is open to all Conference Pass, Exhibitors, Expo Only, and VIP attendees.
“We’re thrilled to have Bertalan Mesko joining us to provide his uniquely entertaining, highly informative and expert visionary insight into the future of research, diagnostics, personalized healthcare, and technology, and how these elements continue to intersect at an increased rate,” commented Joseph Marks, Brand Director for CPhI North America. “CPhI events around the world are renowned for bringing the brightest and best from the pharmaceutical, biopharma and life science industries to provide illumination and insight that highlights innovation, emerging trends and technologies and seeks to address some of the challenges ahead. This year is no exception, and Dr. Mesko’s keynote really is a ‘must see’ session.”
“I’m excited to have the opportunity to connect with CPhI North America and share the latest thinking that underscores the work that we’ve been doing at The Medical Futurist Institute,” added Bertalan Mesko. “We’re in a dynamic era where advanced medical technologies, disruptive innovations and digital communication are empowering patients to become more informed and, as a result, involved in making decisions relating to their health. Digitalization can make personalized care affordable and available, ensuring sustainability and growing our understanding of disease, and advanced diagnostics promote a focus on prevention rather than simply looking at cures.”
The CPhI North America Conference agenda includes discussions on pharmaceutical manufacturing, outsourcing, R&D, drug delivery and supply chain related topics for small and large molecule finished drugs, biopharmaceuticals, and biosimilars/biogenerics. With three designated tracks of programming: two tracks dedicated to pharmaceutical manufacturing, outsourcing, R&D, drug delivery and supply chain related topics for small and large molecule finished drugs, and one track dedicated to advancements in bio-manufacturing, the central theme for 2018’s conference is Fostering Innovation in Drug Development and Manufacturing. Specifically, the conference program will explore the latest developments in the following areas:
  • Novel Drug Delivery Systems – Emerging Technologies
  • R&D Innovation
  • Regulatory Developments
  • Continuous Manufacturing Advancements
  • Process Development
  • Tech Transfer
  • Quality Metrics / Supply Chain Best Practices
  • Bio-Manufacturing Opportunities and Challenges
There is a packed schedule featuring more than 30 sessions presented by leading industry figures and influencers. In addition to the conference program, a series of Insight Briefings, in-depth seminars on technical and business topics, will be freely accessible to all exhibition visitors. Topics include accelerated drug approval programs, the digital transformation of the pharmaceutical industry, supply chain security advancements, amongst others. There will also be a number of free Exhibitor Showcases taking place, providing a platform for industry professionals to present forward-thinking perspectives on their key products, innovations and services. Finally, the pharmaceutical Serialization Series provide a forum for thought leaders to present and discuss the latest insights and developments within the Serialization sector.
CPhI North America will take place April 24-26, 2018 at the Pennsylvania Convention Center in Philadelphia. It will feature an expanded show footprint ideal for networking, sourcing, education and innovation in drug development and manufacturing. Two new zones including a Bioprocessing Zone and the P-MEC Zone, a machinery zone to promote the latest technology in manufacturing equipment, will join legacy zones, InformEx, iCSE, FDF, InnoPack and CPhI.
Registration for CPhI North America is now open at:

Accredited media and analysts can register their interest in attending at:
Note that all press and analyst registrations are evaluated and screened.

The exhibitor floor has strategically been designed to include the following seven zones:
  • Bioprocessing: New for 2018, Bioprocessing zone will provide greater access and pathway to opportunities in the next generation of pharmaceuticals.
  • P-MEC: Also new for 2018. Machinery zone will showcase the latest pharmaceutical equipment, machinery and technology.
  • InformEx: Specialty and fine chemicals zone will address innovative molecule development.
  • CPhI: Manufacturing ingredients zone will support API and excipients
  • iCSE: Drug development zone will highlight world-class CROs specializing in both pre-clinical and clinical research for drug development.
  • FDF: Finished drug products zone will feature leading small and large molecule CDMO/CMOs.
  • InnoPack: Packaging zone will showcase packaging innovation.
More information about CPhI North America and the conference program is available at